Misleading to say brain clots '112,000% more likely' after COVID vaccine than flu shot

Experts say there are critical issues with solely using VAERS vaccination data. (Made Nagi/EPA PHOTO)

What was claimed

Brain clots are 112,000% more likely after COVID-19 vaccine than a flu jab.

Our verdict

Misleading. Unverified, self-reported data do not establish a causal link between vaccines and adverse events.

AAP FACTCHECK - A misleading claim that COVID-19 vaccines are 112,000 per cent more likely to cause brain clots than flu vaccines is spreading on social media.

Experts say the claim is based on unverified self-reports that do not establish a causal link between COVID-19 jabs and adverse health events.

The claim appears in Facebook posts featuring a screenshot of a headline that reads: "COVID Vaccines Pose 112,000% Greater Risk of Brain Clots, Strokes Than Flu."

"Some Doctors took a hard look at Facts and Actual numbers..," the post's caption reads.

One of the misleading posts on Facebook.
The claim fails to mention the data used is self-reported and unverified.

The headline comes from an article published on Substack that cited a paper co-authored by Peter McCullogh, a US cardiologist whose vaccine claims have been debunked multiple times by AAP FactCheck.

The paper said the percentage figure was a proportional reporting ratio (PRR), comparing the frequency of an adverse event reported for one vaccine to another jab.

The authors wrote that the PRR for “cerebral thromboembolism” events, or brain clots, after COVID-19 vaccines when compared to flu vaccines was 1120 (page 623).

The paper calculated the figure using data from the US Vaccine Adverse Event Reporting System (VAERS), where individuals can self-report adverse events after receiving jabs.

However, experts said VAERS data is not verified and does not establish a causal link between vaccines and adverse events.

Assistant Professor Stephen Kissler, a computer scientist studying epidemiology at the University of Colorado Boulder, said that VAERS data lacked a baseline group, such as an unvaccinated control group, for comparisons.

He said a spike in reports after COVID vaccines didn't necessarily mean actual adverse events were any higher than for previous vaccines.

VAERS reporting rates were extremely low before the pandemic, he said, and people were much more likely to report an adverse event after receiving COVID vaccines because they were new, regardless of causation.

COVID-19 vaccine vials.
Vaccine adverse event reporting rates to VAERS were much lower prior to COVID.

Helen Petousis-Harris, a vaccinology expert at the University of Auckland, said VAERS had explicitly warned against using its data to assess the causation of an adverse event or to calculate actual incidence rates.

She said that was due to the lack of a true denominator, underreporting, reporting biases and the unverified nature of the reports.

"VAERS is like a community suggestion box at a busy store; anyone can drop a note in, but you also need to know how many people shopped there to make any meaning of it," Associate Professor Petousis-Harris told AAP FactCheck.

The US Centers for Disease Control and Prevention (CDC), which co-manages VAERS, said anyone can submit reports to the system.

“Some reports can lack details or contain errors. After investigation, scientists find that most events reported to VAERS are not associated with vaccination,” the CDC website said.

The VAERS website also said: "A report to VAERS does not mean that a vaccine caused an adverse event."

Sign outside the CDC, Atlanta, US.
The CDC says VAERS data alone can't establish causation.

Assoc Prof Petousis-Harris said VAERS was an early-warning system for potential safety issues requiring further investigation via more robust studies.

Such studies would examine verified adverse event reports and would be controlled, allowing comparisons to be made, she said.

Assoc Prof Petousis-Harris pointed to a March 2024 US study that found no evidence of significantly elevated stroke risk among 11,001 people aged 65 years or older after they received a Pfizer or Moderna bivalent COVID-19 booster vaccine.

Matt Motta, a health law and policy expert at Boston University, said only clinical trials with other vaccine safety surveillance data could tell researchers how common an adverse event was.

“VAERS isn’t equipped to tell us that, and unfortunately, we have some folks who believe that it is," he told AAP FactCheck.

Professor Motta said there were many reasons self-reports in VAERS were potentially inaccurate.

"People may misreport, people may not understand the symptoms they have. People may lie about symptoms. People don't necessarily have the requisite knowledge necessary to diagnose themselves," he said.

Science Feedback also found the claim was misleading.

The Verdict

Misleading – The claim is accurate in parts but information has also been presented incorrectly, out of context or omitted.

AAP FactCheck is an accredited member of the International Fact-Checking Network. To keep up with our latest fact checks, follow us on Facebook, Twitter and Instagram.

What is AAPNews?

For the first time, Australian Associated Press is delivering news straight to the consumer.

No ads. No spin. News straight-up.

Not only do you get to enjoy high-quality news delivered straight to your desktop or device, you do so in the knowledge you are supporting media diversity in Australia.

AAP Is Australia’s only independent newswire service, free from political and commercial influence, producing fact-based public interest journalism across a range of topics including politics, courts, sport, finance and entertainment.

What is AAPNews?
The Morning Wire

Wake up to AAPNews’ morning news bulletin delivered straight to your inbox or mobile device, bringing you up to speed with all that has happened overnight at home and abroad, as well as setting you up what the day has in store.

AAPNews Morning Wire
AAPNews Breaking News
Breaking News

Be the first to know when major breaking news happens.


Notifications will be sent to your device whenever a big story breaks, ensuring you are never in the dark when the talking points happen.

Focused Content

Enjoy the best of AAP’s specialised Topics in Focus. AAP has reporters dedicated to bringing you hard news and feature content across a range of specialised topics including Environment, Agriculture, Future Economies, Arts and Refugee Issues.

AAPNews Focussed Content
Subscription Plans

Choose the plan that best fits your needs. AAPNews offers two basic subscriptions, all billed monthly.

Once you sign up, you will have seven days to test out the service before being billed.

AAPNews Full Access Plan
Full Access
AU$10
  • Enjoy all that AAPNews has to offer
  • Access to breaking news notifications and bulletins
  • Includes access to all AAPNews’ specialised topics
Join Now
AAPNews Student Access Plan
Student Access
AU$5
  • Gain access via a verified student email account
  • Enjoy all the benefits of the ‘Full Access’ plan at a reduced rate
  • Subscription renews each month
Join Now
AAPNews Annual Access Plan
Annual Access
AU$99
  • All the benefits of the 'Full Access' subscription at a discounted rate
  • Subscription automatically renews after 12 months
Join Now

AAPNews also offers enterprise deals for businesses so you can provide an AAPNews account for your team, organisation or customers. Click here to contact AAP to sign-up your business today.

SEVEN DAYS FREE
Download the app
Download AAPNews on the App StoreDownload AAPNews on the Google Play Store